Hydroxyzinum Aflofarm

Hydroxyzine Hydrochloride, the active ingredient in Hydroxyzinum Aflofarm, is a first‑generation antihistamine presented as an oral tablet for oral use. It is employed to relieve itching associated with allergic skin conditions, to provide anxiolytic effects, and to induce sedation when required.

GNH USA supplies Hydroxyzinum Aflofarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability, regulatory support, and responsive customer service.

Hydroxyzine Hydrochloride is a first‑generation antihistamine that acts on histamine H1 receptors to alleviate symptoms of allergic and anxiety‑related conditions.

Allergic skin conditions (e.g., pruritus, dermatitis): reduces itching and inflammation associated with allergic reactions. Anxiety: provides calming effects that help manage mild to moderate anxiety symptoms. Sedation: induces sleepiness useful for pre‑operative or procedural sedation.

Hydroxyzine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: reduced salivation leading to a dry sensation. - Blurred vision: temporary difficulty focusing. - Constipation: slowed intestinal motility. - Dizziness: light‑headed feeling upon standing. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm that may require medical attention. - Severe hypotension: marked drop in blood pressure causing faintness. - Stevens‑Johnson syndrome: rare skin reaction with blistering and detachment. - Seizures: convulsive episodes in susceptible individuals.

When prescribing Hydroxyzine, clinicians should consider several safety precautions to minimize risk.

Pregnancy: safety category unknown; use only if potential benefit justifies risk. Breastfeeding: caution advised as drug may pass into milk. Elderly patients: increased sensitivity; start with lower dose and monitor. Concomitant CNS depressants: may enhance sedation and respiratory depression. Driving and machinery: avoid operating vehicles or heavy equipment until effects are known. Store below 25°C: keep in the original packaging, protect from moisture and light.

Hydroxyzine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Central nervous system depressants (e.g., alcohol, benzodiazepines): may cause profound sedation or respiratory depression. - Monoamine oxidase inhibitors (MAOIs): risk of additive anticholinergic effects and hypotension. - QT‑prolonging agents (e.g., certain antiarrhythmics): increase risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs (e.g., diphenhydramine): may intensify dry mouth and constipation. - CYP3A4 inhibitors (e.g., erythromycin): can raise hydroxyzine plasma levels. - Antihypertensive medications: additive blood pressure‑lowering effect. - Antidepressants (e.g., SSRIs): may increase risk of serotonin syndrome, though rare.